Concept
Method for conducting Famotidine retrospective cohort study
- Data were obtained from two telephone interviews and two written questionnaires
- Information regarding patient demographics, comorbidities, COVID-19 test results, famotidine use, drug-related side effects, temperature readings, oxygen saturation levels and symptom scores were collected
- Longitudinal severity scores for five symptoms (cough, shortness of breath, fatigue, headaches + ansomnia) were collected
- Patients reported symptom scores on a scale of 1-4, where 1 corresponds to not affected and 4 corresponds to severely affected
- Scores were obtained prior to COVID-19 illness, the day before famotidine (day -1), the day the patients started taking famotidine (day 0) and days 1,2, 7, and 14 after taking the drug
0
1
Updated 2020-08-13
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences